Insider Shake-Up at TransDigm, Cytokinetics, ASE, Alexandria, Itau

Insiders have been trading these 5 stocks: ((TDG)), ((CYTK)), ((ASX)), ((ARE)) and ((ITUB)). Here is a breakdown of their recent trades and their value.

Director Nicholas Howley drew attention at TransDigm Group after selling 10,132 shares of company stock in a single transaction. The move, valued at $12,817,517, may prompt investors to reassess insider sentiment even as the aerospace supplier continues to navigate a complex defense and commercial aviation landscape.

At Cytokinetics, Director Fady Ibraham Malik executed a sale of 3,500 shares, bringing in $229,915. This insider transaction arrives as the biotech firm advances its pipeline of cardiovascular and neuromuscular therapies, giving market watchers fresh data on how leadership is managing personal exposure to the company’s volatile share price.

ASE Technology Holding Co saw a series of sizable insider moves, starting with GM, ASE Inc. Chung-Li Branch Tien-Szu Chen selling 530,000 shares for a striking $247,134,800. Director Jeffrey Chen followed with two separate disposals of 27,000 shares each, worth $12,758,940 and $12,253,500, underscoring active insider portfolio adjustments at the semiconductor packaging giant.

Real estate investors noted activity at Alexandria Equities as EVP – Cap Market & Co-Lead – LS Hallie E. Kuhn sold 536 shares. The sale, totaling $25,835, adds a small but notable data point to insider trends at the life science–focused REIT, which manages a high-value portfolio of lab and innovation campuses across key urban markets.

In the financial sector, Chief People and MKT Officer Sergio Guillinet Fajerman reduced his stake in Itau Unibanco by selling 39,477 shares. The transaction, valued at $376,215, offers a glimpse into executive trading behavior at Latin America’s banking heavyweight, as investors weigh macroeconomic conditions and shifting profitability in regional lending and payments.